Philips Leads the Way in Medical Innovations and Patents

Philips Sets New Standards in Medical Technology Innovation

Royal Philips (NYSE: PHG, AEX: PHIA), a frontrunner in health technology, has made a remarkable impact in 2024, standing out as the top applicant in the medical technology sector at the European Patent Office (EPO). This achievement, with an impressive 594 Medtech patent applications, highlights Philips' devoted mission to revolutionize healthcare. Through the integration of informatics and artificial intelligence (AI), the company aims to enhance workflow efficiency, improve the quality of patient care, and reduce overall care costs.

A Legacy of Innovation

With a substantial history that spans 134 years, Philips has been on a relentless journey of innovation, continuously advancing its research and development endeavors worldwide. In 2024 alone, Philips improved the health and well-being of nearly 2 billion individuals, edging closer to its ambitious target of benefitting 2.5 billion lives by 2030. By staying attuned to customer needs, Philips strives to empower healthcare professionals to elevate patient care.

Innovative Technologies Redefining Healthcare

A significant segment of Philips' research and development investments—about 50%—is directed towards harnessing the power of informatics and AI. These technologies play a crucial role in creating solutions not only in hospital settings but also for patients at home. Some of the groundbreaking innovations introduced by Philips in 2024 include:

• The advanced Azurion image-guided therapy system, designed for minimally invasive diagnoses and treatments for stroke and neurovascular patients.
• FDA-cleared AI tools incorporated within the EPIQ CVx and Affiniti CVx ultrasound systems. These advancements are poised to enhance cardiovascular imaging, significantly boosting productivity and reinforcing Philips' leading position in cardiovascular ultrasound on a global scale.
• The state-of-the-art Philips Spectral CT 7500 RT, which facilitates personalized radiation therapy planning, ultimately providing better care for a greater number of cancer patients.
• The FDA-approved LumiGuide Navigation Wire, utilizing fiber optics to minimize radiation exposure during minimally invasive procedures.

Philips made a record of a total of 1,231 European patent applications across a variety of sectors in 2024, solidifying its reputation as a leading innovator in this domain.

Recognition for Innovative Contributions

Adding to its accolades, Philips has recently been recognized in the Clarivate Top 100 Global Innovators for 2025, marking the twelfth consecutive year the company has achieved this recognition. This prestigious acknowledgement underscores Philips' leading position in the global innovation landscape.

In 2024, Royal Philips invested approximately EUR 1.7 billion into research and development. This investment, amounting to over 9% of sales, notably exceeds industry standards, reinforcing its commitment to driving improvements in patient care and health outcomes worldwide. The vast intellectual property portfolio of Philips includes 50,500 patents, 30,500 trademarks, and 150,000 design rights, showcasing the company's innovation prowess.

Contact for More Information

For further inquiries, please reach out to:

Elco van Groningen
Philips Global External Relations
Tel.: +31 6 8103 9584
E-mail: media@philips.com

About Royal Philips

Royal Philips is a key player in health technology, dedicated to enhancing individuals' health through impactful innovations. The company combines advanced technology with clinical and consumer insights to create health solutions that benefit both consumers and healthcare providers. With its headquarters situated in the Netherlands, Philips continues to lead in vital sectors such as diagnostic imaging, ultrasound, image-guided therapy, and monitoring solutions.

In 2024, Philips reported sales of EUR 18 billion and has a workforce of approximately 67,800 employees, serving markets across 100 countries. More details about Philips and its innovations can be found at www.philips.com/newscenter.

Frequently Asked Questions

What is Philips' focus area in health technology?

Philips focuses on improving health and well-being through meaningful innovations in both hospital and home care solutions.

How many patent applications did Philips file in 2024?

In 2024, Philips filed 594 patent applications in the medical technology sector, the most of any company in Europe.

What notable innovations has Philips launched recently?

Philips introduced various innovations, including the Azurion therapy system and the Spectral CT 7500 RT, aimed at enhancing patient care.

How much does Philips invest in research and development?

Philips invested approximately EUR 1.7 billion in R&D in 2024, which represents over 9% of their sales.

Is Philips recognized for its innovation leadership?

Yes, Philips has been included in the Clarivate Top 100 Global Innovators list for 12 consecutive years, underscoring its innovation leadership.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.